These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17396105

  • 1. Imatinib for the treatment of rheumatic diseases.
    Paniagua RT, Robinson WH.
    Nat Clin Pract Rheumatol; 2007 Apr; 3(4):190-1. PubMed ID: 17396105
    [No Abstract] [Full Text] [Related]

  • 2. Imatinib mesylate: an innovation in treatment of autoimmune diseases.
    Azizi G, Mirshafiey A.
    Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):259-67. PubMed ID: 23947692
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia.
    Murphy M, Close J, Lottenberg R, Rajasekhar A.
    Am J Med Sci; 2014 Mar; 347(3):254-5. PubMed ID: 24553361
    [No Abstract] [Full Text] [Related]

  • 12. Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate.
    Yalamanchili K, Liu D, Seiter K.
    Leukemia; 2007 Mar; 21(3):577-8. PubMed ID: 17230224
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-standing remission of Crohn's disease under imatinib therapy in a patient with Crohn's disease.
    Magro F, Costa C.
    Inflamm Bowel Dis; 2006 Nov; 12(11):1087-9. PubMed ID: 17075351
    [No Abstract] [Full Text] [Related]

  • 17. Treatment for plexiform neurofibromas in patients with NF1.
    Ardern-Holmes SL, North KN.
    Lancet Oncol; 2012 Dec; 13(12):1175-6. PubMed ID: 23099008
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reversal of cardiac abnormalities in a young man with idiopathic hypereosinophilic syndrome using a tyrosine kinase inhibitor.
    Ascione L, De Michele M, Accadia M, Spadaro P, Rumolo S, Tuccillo B.
    Eur J Echocardiogr; 2004 Oct; 5(5):386-90. PubMed ID: 15341874
    [Abstract] [Full Text] [Related]

  • 20. First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate.
    Eskazan AE, Ayer M, Kantarcioglu B, Arica D, Demirel N, Aydin D, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.
    Br J Haematol; 2014 Oct; 167(1):139-41. PubMed ID: 24815307
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.